Zevra Therapeutics, Inc. rose 2.33% in after-hours trading. The market's euphoria over AI-driven optimism, as seen with Nvidia's valuation surge, likely contributed to the stock's upward movement. This optimism overshadowed geopolitical tensions and trade war risks, driving momentum in the market.
Comments
No comments yet